TABLE 8.
Without Risk Genes in Model
|
With Risk Genes in Model
|
|||
---|---|---|---|---|
OR 95% CI | P-value | OR 95% CI | P-value | |
Age (<30 y/o vs. >=30 y/o) | 3.88 (1.96–7.69) | <0.001 | 3.57 (1.71–7.46) | 0.001 |
Gender (female vs. male) | 0.56 (0.37–0.85) | 0.006 | 0.58 (0.37–0.91) | 0.02 |
Residency (urban vs. rural) | 1.01 (0.68–1.49) | 0.98 | 1.05 (0.68–1.62) | 0.82 |
Positive family history of IBD | 2.41 (1.31–4.42) | 0.005 | 2.75 (1.42–5.31) | 0.003 |
Tobacco use | 1.84 (1.25–2.71) | 0.002 | 2.06 (1.35–3.14) | 0.001 |
Jewish ethnicity | 17.1 (2.12–138.3) | 0.008 | 20.1 (2.16–186.8) | 0.008 |
Carrier of NOD2 mutation | — | 4.45 (2.68–7.38) | <0.001 | |
Carrier of ATG16L1 | — | 1.88 (1.09–3.24) | 0.02 | |
Carrier of rs10889677 | — | 2.13 (1.39–3.28) | 0.001 | |
Carrier of IBD5_IGR2230 | — | 2.16 (1.30–3.59) | 0.003 |